Press release: Sanofi appoints Paulo Fontoura as Global Head of R&D.
Article excerpt
Highlighted: the sentence this signal was extracted from
Press release: Sanofi appoints Paulo Fontoura as Global Head of R&D. GlobeNewswire | Sanofi Winthrop Industrie Yesterday at 11:00pm PDT Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1, 2026. He will be a member of Sanofi's Executive Committee, based in Paris, and will report to Chief Executive Officer Belén Garijo. As head of R&D Pharma, Paulo will lead Sanofi's end-to-end innovation engine, spanning research, translational medicine, clinical development, and regulatory affairs, with responsibility for advancing a differentiated pipeline and accelerating the delivery of transformative medicines to patients. Paulo succeeds Dr. Houman Ashrafian, who has decided to pursue an opportunity outside the company. With more than 25 years of experience spanning academic medicine, translational science, clinical development, and pharmaceutical innovation, Paulo joins Sanofi at an important moment as the company continues to advance its R&D transformation and progress a pipeline of new medicines across multiple therapeutic areas. A board-certified neurologist and physician-scientist, Paulo has played a leading role in the development of significant medicines across neuroscience...
Keep reading with a free account
The rest of this article, and every signal for Sanofi, is in your free account.
